. >> brent saunders is too young. >> though he could take over the combined company as ceo. >> that'scompany, if they finish that deal with teva, a pristine balance sheet. >> the splits would fall into the window for inversions so it could be beneficial. you need at least 40% of the ownership to be by the company being acquired that would be in a pfizer/allergen deal. am i changing your thoughts? >> yeah. brent has been a regular "mad money" guest. he has broad ambitions. i'm only holding from that. i don't want it to be like if something falls through, that's it, man. >> i want to share that. it is constant conversation among -- >> balance sheet is so much different valiant versus allergen. allergen is getting so much money from the generic business. >> valiant has a leverage trade of five times. allergen -- >> whistle clean balance sheet. 40 billion coming in. >> yeah. who knows, it could go the other way. >> brent saunders, money maker. >> need access to capital. >> pfizer could be a classic credit. >> investment grade has not been affected. that's why ab inbev will have no problem

brent saunders, president of allergan, agn. stay with cramer. . >>> coming up, when it comes to la quinta, say what the heck? what is the old hotel chain dropping 15% after bad news on guidance and a major sweep shakeup. can we help you get back on track? or is it time to pack your backs? cramer is on the case. coming up. . that's where at&t can help. at&t's innovative solutions connect machines and people... to keep your internet of things in-sync, in real-time. leaving you free to focus on what matters most. >>> it got personal this morning between fed president and "squawk box" or at least it got personal on his ends. >> i have a message for your friends cramer, the fed cannot criminally raise stock prices. so the idea that it's all of the fed is going one way or the other and this is what's dragging the stockmarket is not true. he's one of the great people at looking at businesses. what's the profitability of the business. what's this. worth and you know to have him cheerleading for low rates, you know, 24 hours a day is i

brent saunders will not be involved with pfizer me. >> he has shown a willingness to sel sell. >> i'maying -- >> buyer/seller. >> if you bet against brent saunders you're betting against the -- the most aggressive man in fapharma. he's like a general manager ins nfl, look s at talent who do yo buy? don't count him out. >> must have a lot of clients. the stock is higher. >> i don't know. >> it's going up. don't worry they'll do something. >> with all -- with all of that, the dow is up 35. led by chevron. haven't seen that every day. >> chevron? >> let's get to bob pisani on the floor. >> 2/1 advancing to declining stocks. exxon also helping the dow. financials, industrials, technology leading. utilities are on the down side. nikkei was up slightly. bank of japan left rates unchanged. the head of the bank of japan fairly upbeat, he said the fed rate hike would be a positive. i was surprised to see that. he said it would be a positive. by the way, a bit more fallout from mr. abbe, the japanese prime minister's comments on japanese telecom bills. he weighed in saying japanese consumers ar

this guy said i'm restraining -- brent saunders and allergan said they have not down that irresistiblends, jpmorgan reiterates today. sanders and hiller reevaluating and martin strelly, and counteracted the valeant plus side, but this is an election year. i cannot think of a bigger opponent that everyone would agree on, but we hate valeant. >> that guy galvan iced, that 32-year-old guy -- what's his name. >> i don't know, anyway, he galvanized -- >> how could they not? >> he's like electric llexl lut. >>> no confidence really in the overall market? >> yes, and i think it's important, here again, when you look at they stocks, you have to realize how much you're done. bristol-myers is upgraded by ubs. 109 to 91, diversified pharma. the stock was up yesterday. i think people are saying i want to be in safety safety safety. the aaa balance sheet, but it's what you recommend when you're at goldman sachs like i was during a bearish phase. i like heinz and j. & j. you recommend those stocks, you come back and the guy on the street isn't say you idiot that's a win in this market. >> it is. you